Nonglycemic effects of dipeptidyl peptidase-4 inhibitors

The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: A S Ametov, L L Kamynina
Materialtyp: Artigo
Språk:Russo
Publicerad: "Consilium Medicum" Publishing house 2013-01-01
Serie:Терапевтический архив
Ämnen:
type 2 diabetes mellitus
dipeptidyl peptidase-4 inhibitors
sitagliptin
nonglycemic effects
Länkar:https://ter-arkhiv.ru/0040-3660/article/view/31226
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk